You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
西隴科學(002584.SZ)子公司艾克韋生物2019新型冠狀病毒核酸檢測試劑盒通過檢測
格隆匯 02-02 17:47

格隆匯2月2日丨西隴科學(002584.SZ)公佈,2020年1月27日,山東省藥品監督管理局(http://mpa.shandong.gov.cn)發佈通知,公司控股子公司山東艾克韋生物技術有限公司(“艾克韋生物”)2019新型冠狀病毒核酸檢測試劑盒通過檢測,相關內容如下:26日下午,省藥監局接到山東艾克韋生物技術有限公司研發的2019新型冠狀病毒核酸檢測試劑盒,省器械檢驗中心立即組織檢驗,並於27日上午9點完成所有項目檢驗,產品符合技術要求,成為我省法定檢驗機構檢定合格的首個新型冠狀病毒檢測產品。在獲得國家藥監局的上市批件後,這種試劑盒將被髮往各地醫院,用於測定疑似患者的樣本中是否有新型冠狀病毒。

目前,公司已啟動緊急恢復生產預案,定單能保證供應。

艾克韋生物冠狀病毒系列檢測試劑產品,可用於近期出現的新型冠狀病毒的檢測,不用於治療,具體供應情況取決於此次疫情的相關防控情況,不會對公司未來經營成果產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account